Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

First-in-man clinical study of SCMod1 [Modi-1 / AMPLIVANT combination] for cancer

Next Previous
Trial Profile

First-in-man clinical study of SCMod1 [Modi-1 / AMPLIVANT combination] for cancer

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Modi-1 (Primary) ; Antineoplastics
  • Indications Breast cancer; Endometrial cancer; Head and neck cancer; Osteosarcoma; Ovarian cancer; Renal cancer; Sarcoma; Solid tumours; Triple negative breast cancer
  • Focus Adverse reactions; First in man

    • Most Recent Events

    • 14 Apr 2022 Status changed from planning to recruiting, according to an ISA Pharmaceuticals media release.
    • 10 May 2019 According to a Scancell media release, the company expects to initiate this study in Q1 2020.
    • 10 May 2019 According to a Scancell media release, the company has appointed six world-leading clinicians to establish a Clinical Advisory Board (CAB) which will guidance and support Moditope, to enter into clinic in multiple tumour types, including head and neck, breast and ovarian cancer.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top